Xingyu Zhou

An acid-responsive nanoagonist delivering chemotherapy-derived tumor antigens to assist cancer immunotherapy

Abstract Background Immunotherapy is being actively explored for malignant tumors through various approaches, with recent success exemplified by immune checkpoint inhibitors (ICIs), which function by restoring T-cell activity to eliminate tumor cells. Some chemotherapeutic drugs...